Zobrazeno 1 - 10
of 386
pro vyhledávání: '"Anand A. Kulkarni"'
Autor:
Anand V. Kulkarni, Parthasarathy Kumaraswamy, Balachandran Menon, Anuradha Sekaran, Anuhya Rambhatla, Sowmya Iyengar, Manasa Alla, Shantan Venishetty, Sumana Kolar Ramachandra, Giri V. Premkumar, Mithun Sharma, P. Nagaraja Rao, Duvvur Nageshwar Reddy, Amit G. Singal
Publikováno v:
Journal of Liver Cancer, Vol 24, Iss 2, Pp 224-233 (2024)
Backgrounds/Aims Hepatocellular carcinoma (HCC) is generally diagnosed at an advanced stage, which limits curative treatment options for these patients. Locoregional therapy (LRT) is the standard approach to bridge and downstage unresectable HCC for
Externí odkaz:
https://doaj.org/article/17f05de2f0f34730afdc39e17c3b94c5
Autor:
Akash Roy, Arka De, Anand V. Kulkarni, Surabhi Jajodia, Usha Goenka, Awanish Tewari, Nikhil Sonthalia, Mahesh K. Goenka
Publikováno v:
Journal of Obesity & Metabolic Syndrome, Vol 33, Iss 3, Pp 222-228 (2024)
Background : Steatotic liver disease (SLD) encompasses metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-associated liver disease (AALD) at extremes as well as an overlap group termed MASLD with increased alcohol intake (Me
Externí odkaz:
https://doaj.org/article/5ce9c241bf4b4b9d939f3a1cfce6114c
Autor:
Govardhan, Bale, Anand, V. Kulkarni, Nagaraja Rao, Padaki, Balachandran Menon, P., Mithun, Sharma, Sasikala, Mitnala, Sowmya, T.R., Anuradha, Sekaran, Smita, C. Pawar, Nageshwar Reddy, D., Ravikanth, Vishnubhotla
Publikováno v:
In Journal of Clinical and Experimental Hepatology July-August 2024 14(4)
Autor:
Anand V. Kulkarni, Moiz Vora, Ramyasri Ramagundam, Mithun Sharma, D. Nageshwar Reddy, P.N. Rao, S. Iyengar, D. Gujjarlapudi, A. Gupta, M. Alla, S. Venishetty, R. Gupta
Publikováno v:
Gastro Hep Advances, Vol 3, Iss 1, Pp 55-57 (2024)
Externí odkaz:
https://doaj.org/article/ed01d52882654b3eb805341a15dde918
Autor:
Anand V. Kulkarni, Harshvardhan Tevethia, Karan Kumar, Madhumita Premkumar, Mark D. Muttaiah, Atsushi Hiraoka, Takeshi Hatanaka, Toshifumi Tada, Takashi Kumada, Satoru Kakizaki, Arndt Vogel, Richard S. Finn, Padaki Nagaraja Rao, Anjana Pillai, Duvvur Nageshwar Reddy, Amit G. Singal
Publikováno v:
EClinicalMedicine, Vol 63, Iss , Pp 102179- (2023)
Summary: Background: Atezolizumab-bevacizumab (atezo-bev) is recommended as first-line therapy for patients with unresectable hepatocellular carcinoma (uHCC). However, its effectiveness and safety in other populations, including those with Child-Turc
Externí odkaz:
https://doaj.org/article/ea732d774da342e591c1f6808e94fa44
Autor:
Luis Antonio Díaz, Eduardo Fuentes-López, Gustavo Ayares, Francisco Idalsoaga, Jorge Arnold, María Ayala Valverde, Diego Perez, Jaime Gómez, Rodrigo Escarate, Alejandro Villalón, Carolina A. Ramírez, Maria Hernandez-Tejero, Wei Zhang, Steve Qian, Douglas A. Simonetto, Joseph C. Ahn, Seth Buryska, Winston Dunn, Heer Mehta, Rohit Agrawal, Joaquín Cabezas, Inés García-Carrera, Berta Cuyàs, Maria Poca, German Soriano, Shiv K. Sarin, Rakhi Maiwall, Prasun K. Jalal, Saba Abdulsada, Fátima Higuera-de-la-Tijera, Anand V. Kulkarni, P. Nagaraja Rao, Patricia Guerra Salazar, Lubomir Skladaný, Natália Bystrianska, Ana Clemente-Sanchez, Clara Villaseca-Gómez, Tehseen Haider, Kristina R. Chacko, Gustavo A. Romero, Florencia D. Pollarsky, Juan Carlos Restrepo, Susana Castro-Sanchez, Luis G. Toro, Pamela Yaquich, Manuel Mendizabal, Maria Laura Garrido, Sebastián Marciano, Melisa Dirchwolf, Victor Vargas, César Jiménez, Alexandre Louvet, Guadalupe García-Tsao, Juan Pablo Roblero, Juan G. Abraldes, Vijay H. Shah, Patrick S. Kamath, Marco Arrese, Ashwani K. Singal, Ramon Bataller, Juan Pablo Arab
Publikováno v:
JHEP Reports, Vol 5, Iss 8, Pp 100727- (2023)
Background & Aims: Model for End-Stage Liver Disease (MELD) score better predicts mortality in alcohol-associated hepatitis (AH) but could underestimate severity in women and malnourished patients. Using a global cohort, we assessed the ability of th
Externí odkaz:
https://doaj.org/article/497553cb7c884b90bbd7340ddb54ae9c
Autor:
Anand V. Kulkarni, Raghuram Reddy, Juan Pablo Arab, Mithun Sharma, Sameer Shaik, Sowmya Iyengar, Naveen Kumar, Sabreena, Rajesh Gupta, Giri Vishwanathan Premkumar, Balachandran Palat Menon, Duvvur Nageshwar Reddy, Padaki Nagaraja Rao, K. Rajender Reddy
Publikováno v:
Annals of Hepatology, Vol 28, Iss 4, Pp 101098- (2023)
Introduction and Objectives: Lately, there has been a steady increase in early liver transplantation for alcohol-associated hepatitis (AAH). Although several studies have reported favorable outcomes with cadaveric early liver transplantation, the exp
Externí odkaz:
https://doaj.org/article/27216afc72ee4c39bbe12e9c693da643
Autor:
Rakesh Kumar Jagdish, Akash Roy, Karan Kumar, Madhumita Premkumar, Mithun Sharma, Padaki Nagaraja Rao, Duvvur Nageshwar Reddy, Anand V. Kulkarni
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
Cirrhosis transcends various progressive stages from compensation to decompensation driven by the severity of portal hypertension. The downstream effect of increasing portal hypertension severity leads to various pathophysiological pathways, which re
Externí odkaz:
https://doaj.org/article/d2bf6bb845c049a28bf3e282aa346c3c
Autor:
Anand V. Kulkarni, Shiv Kumar Sarin
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism, Vol 14 (2023)
Nonalcoholic fatty liver disease (NAFLD), once considered a benign condition, has been associated with several cardiometabolic complications over the past two decades. The worldwide prevalence of NAFLD is as high as 30%. NAFLD requires the absence of
Externí odkaz:
https://doaj.org/article/b49f19acf7ca492ea500643e3dcb3129
Autor:
Anand V. Kulkarni, Madhumita Premkumar, Karan Kumar, Juned A. Khan, Baqar A. Gora, Sowmya Tirumalle, Sameer Shaik, Mithun Sharma, Rajesh Gupta, Nageshwar D. Reddy, Padaki N. Rao
Publikováno v:
Portal Hypertension & Cirrhosis, Vol 1, Iss 1, Pp 15-22 (2022)
Abstract Aim Nonselective beta‐blockers (NSBBs) can reduce the incidence of complications in patients with cirrhosis and prolong survival. The safety and efficacy of NSBBs in real‐world settings in patients with acute‐on‐chronic liver failure
Externí odkaz:
https://doaj.org/article/7bdfec2039b2488b829402fe59c3d2d7